Jack Lenz

Jack Lenz

Auto-generated profile, based on publicly available information

Jack Lenz

Department of Genetics, Albert Einstein College of Medicine

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
Lorenzo AgoniLorenzo Agoni
Lorenzo Agoni
Chandan GuhaChandan Guha
Chandan Guha
JLJack Lenz
Jack Lenz
Human endogenous retroviruses (HERVs) are transcribed in many cancers including prostate cancer. Human endogenous retrovirus K (HERV-K) of the HML2 subtype is the most recently integrated and most intact retrovirus in the human genome, with many of the viral genomes encoding full- or partial-length viral proteins. To assess transcripts of HERV-K in prostate cancer cell lines and identify the specific HERV-K elements in the human genome that are transcribed, reverse transcriptase-PCR (RT-PCR) and cDNA sequencing were undertaken. Strand-specific RT-PCR, plasmid subcloning, and cDNA sequencing detected the presence of HERV-K(HML2) coding strand transcripts within four prostate cell lines (LNCaP, DU145, PC3, and VCaP). RT-PCR across splice junctions revealed splicing variants for env gene mRNA in three cell lines, two involving previously undescribed alternative splice sites. To determine the HERV-K loci from which the transcripts arose, RepeatMasker was used to compile a list of over 200 HERV-K internal genome segment fragments and over 1,000 HERV-K solo long terminal repeat (LTR) fragments in the human genome. Surprisingly, the sequences identified from internal positions of the viral genome were mostly smaller segments, while the LTRs were relatively intact. Possible reasons for this are discussed. The transcripts in the cell lines tested, arose from several HERV-K loci, with some proviruses being detected in multiple cell lines and others in only one of the four used. In some instances, transcripts from viral antisense strands was also detected. In addition, transcripts from both strands of solo LTRs were detected. These data show that transcripts from HERV-K loci commonly occur in prostate cancer cell lines and that transcription of either strand can occur. They also emphasize the importance of single nucleotide level analysis to identify the specific, individual HERV-K loci that are transcribed, and indicate that HERV-K expression in prostate cancer warrants further study.

8 April 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
JLJack Lenz
Jack Lenz
Retroviruses comprise over 8% of the human genome (1, 2). Human endogenous retroviruses (HERVs) exist as DNA remnants of infections that occurred in germ lineage cells of our ancestors. Most of this viral DNA is mutated, often including various large disruptions, but some components are intact or otherwise functional. What viral components exist in human genomes, and what gene products do they encode that might interact with the nonviral parts of us? When did they arrive in the genomes of our ancestors, and are they still active today? Does an intact, infectious, retroviral provirus lurk in the genomes of some of us? Wildschutte et al. (3) shed new light on these issues by characterizing the most recently acquired proviruses in human genomes, a subset of the virus HERV-K called HML-2 (for human mouse mammary tumor virus like-2), which are present at various allele frequencies <1 in the human population, i.e., not in everyone. Retrovirus replication involves reverse transcription of the RNA genome from viral particles into DNA, which then integrates into host cell DNA. The viral DNA contains two long terminal repeats (LTRs) (Fig. 1). Full-length integrated DNAs, called proviruses, are permanently associated with the infected cell and its descendants unless stochastic mutational events delete them. Endogenous retroviruses are adapted to infect germ lineage cells, and their inserted DNAs become parts of the genome of the infected species, and are subject to selection processes and genetic drift over evolutionary time. In the absence of selective pressure on the host to maintain the viral DNAs or their components in intact condition, these elements inevitably accumulate mutations over evolutionary time that cause functional decay, including the very common event of homologous recombination between the two LTRs that generates solo LTRs (Fig. 1). Each viral DNA insertion also has unique mutations that …

1 August 1991 in Journal of Virology
Verified
Journal Article
Open access
PDP J Dillon
P J Dillon
JLJ Lenz
J Lenz
CRC A Rosen
C A Rosen
A replication-competent Akv murine leukemia virus-based vector encoding the human immunodeficiency virus tat cDNA under control of the simian virus 40 early promoter sequences was constructed. The simian virus 40 tat sequences were placed within the U3 region of the 3' long terminal repeat. The resulting virus, derived by transfection, replicated efficiently in mouse NIH 3T3 cells and maintained the tat cDNA insert. It has been suggested that Tat function requires the presence of a human-specific cofactor, which is absent in murine cells. However, infection of murine cells with the Akv virus encoding tat resulted in significant transactivation of a human immunodeficiency virus long terminal repeat-driven reporter gene, indicating that human cofactors are not always required for Tat function. The vector system described may be useful for introduction of foreign genes in vivo and in whole animals when virus spread is required for efficient infection and levels of gene expression.

26 June 2025 in eLife preprints
Verified
Preprint
Open access
AAAnne Van Arsdale
Anne Van Arsdale
OMOlga Mescheryakova
Olga Mescheryakova
SGSonia Gallego
Sonia Gallego
EMElaine C Maggi
Elaine C Maggi
BHBryan Harmon
Bryan Harmon
JLJack Lenz
Jack Lenz
Almost all cervical cancers are caused by human papillomaviruses (HPVs). In most cases, HPV DNA is integrated into the human genome. We found that tumor-specific, HPV-human DNA junctions are detectable in serum cell-free DNA of a fraction of cervical cancer patients at the time of initial treatment and/or at six months following treatment. Retrospective analysis revealed these junctions were more frequently detectable in women in whom the cancer later recurred. We also found that cervical cancers caused by HPV types outside of phylogenetic clade α9 had a higher recurrence frequency than those caused by α9 types in both our study and The Cancer Genome Atlas cervical cancer database, despite the higher prevalence of α9 types including HPV16 in cervical cancer. Thus, HPV-human DNA junction detection in serum cell-free DNA and HPV type determination in tumor tissue may help predict recurrence risk. Screening serum cell-free DNA for junctions may also offer an unambiguous, non-invasive means to monitor absence of recurrence following treatment.

16 September 2024 in medRxiv
Verified
Preprint
Open access
PDF file
AAAnne Van Arsdale
Anne Van Arsdale
OMOlga Mescheryakova
Olga Mescheryakova
SGSonia Gallego
Sonia Gallego
EMElaine C. Maggi
Elaine C. Maggi
BHBryan Harmon
Bryan Harmon
JLJack Lenz
Jack Lenz
Almost all cervical cancers are caused by human papillomaviruses (HPVs). In most cases, HPV DNA is integrated into the human genome. We found that tumor-specific, HPV-human DNA junctions are detectable in serum cell-free DNA of a fraction of cervical cancer patients at the time of initial treatment and/or at six months following treatment. Retrospective analysis revealed these junctions were more frequently detectable in women in whom the cancer later recurred. We also found that cervical cancers caused by HPV types outside of phylogenetic clade α9 had a higher recurrence frequency than those caused by α9 types in both our study and The Cancer Genome Atlas cervical cancer database, despite the higher prevalence of α9 types including HPV16 in cervical cancer. Thus, HPV-human DNA junction detection in serum cell-free DNA and HPV type determination in tumor tissue may help predict recurrence risk. Screening serum cell-free DNA for junctions may also offer an unambiguous, non-invasive means to monitor absence of recurrence following treatment.

10 May 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
AAAnne Van Arsdale
Anne Van Arsdale
NPNicole E. Patterson
Nicole E. Patterson
EMElaine C. Maggi
Elaine C. Maggi
Lorenzo AgoniLorenzo Agoni
Lorenzo Agoni
KDKoenraad Van Doorslaer
Koenraad Van Doorslaer
CMCristina Montagna
Cristina Montagna
Cervical carcinogenesis, the second leading cause of cancer death in women worldwide, is caused by multiple types of human papillomaviruses (HPVs). To investigate a possible role for HPV in a cervical carcinoma that was HPV-negative by PCR testing, we performed HPV DNA hybridization capture plus massively parallel sequencing. This detected a subgenomic, URR- E6-E7-E1 segment of HPV70 DNA, a type not generally associated with cervical cancer, inserted in an intron of the B-cell lymphoma/leukemia 11B ( BCL11B ) gene in the human genome. Long range DNA sequencing confirmed the virus and flanking BCL11B DNA structures including both insertion junctions. Global transcriptomic analysis detected multiple, alternatively spliced, HPV70- BCL11B , fusion transcripts with fused open reading frames. The insertion and fusion transcripts were present in an intraepithelial precursor phase of tumorigenesis. These results suggest oncogenicity of HPV70, identify novel BCL11B variants with potential oncogenic implications, and underscore the advantages of thorough genomic analyses to elucidate insights into HPV-associated tumorigenesis. Statement of Significance: Multiple HPV types have been defined as high risk for cancer causation. However, genomic analyses applied here detected a non-high risk HPV in a carcinoma that was HPV negative, and elucidated virally-associated tumorigenic genetic events. This stresses the importance of thorough genomic analyses for elucidating genetic processes in HPV-associated tumorigenesis. Author Summary: Cervical cancer is the second leading cause of cancer death in women worldwide. Most cervical cancers are caused by one of 15 high risk types of human papilloma viruses (HPVs), although hundreds of types of HPVs exist. We used a series of contemporary genomics analyses to examine a cervical cancer that was clinically determined to be HPV-negative. These detected DNA of HPV70, an HPV type not considered to be high risk, in the tumor. Approximately half of the HPV70 DNA genome was present including the viral E6 and E7 oncogenes. Moreover, the viral DNA was inserted into the BCL11B gene in the human genome. BCL11B is known to be mutated in certain human cancers. The HPV70 DNA interacted with the human BCL11B gene to produce altered forms of RNA encoding unusual, truncated forms of the BCL11B protein. These results strongly implicate HPV70 as being oncogenic, suggest that this tumor was caused by a combination of viral oncogenes plus the virally-activated human BCL11B gene, demonstrate novel truncated BCL11B variants with oncogenic implications, and underscore the advantages of thorough genomic analyses to elucidate HPV tumorigenesis insights